Dr. Erlina Burhan is a Clinical Senior Lecturer in the Department Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Indonesia. In 2020, She initiated the Respiratory and Tuberculosis Research and Training Centre (SATURATE) and currently lead this research unit in Persahabatan General Hospital, Indonesia.
Dr. Erlina graduated with her Medical Doctor from Universitas Andalas, Indonesia in 1989 and Masters in Community Health in 1995 from Heidelberg University, Germany. She accomplished her residency in pulmonology in 2004 and consultant of respiratory infection in 2010. She was awarded her Ph.D degree in Medicine by Universitas Indonesia in 2012 and her doctoral research focused on Tuberculosis clinical research.
Dr. Erlina is a national principal investigator (Indonesia) on the TRUNCATE-TB trial (a strategy trial of 2 months of treatment for drug-susceptible TB done across a network of 18 sites in Asia and Africa). Beside her effort on Tuberculosis elimination, during COVID-19 pandemic she has been contributing in global and national effort against COVID-19 pandemics through guideline development, strategic partnership and leadership in many global studies investigating monoclonal antibody and mRNA vaccine against COVID-19. After seeing COVID-19 pandemic was stable, in 2022, she was appointed to be national principal investigator of an operational study investigating BPaL regiment for Pre-XDR TB patients in Indonesia. In 2023, she is appointed as a member of board director of Stop TB partnership (Private Sector Provide). Her current research interest is on the TB drug regiment strategies, TB vaccine and its impact on health outcomes, and other respiratory infection.
